Senseonics Holdings, Inc. (NYSE:SENS) Receives $1.55 Consensus PT from Analysts

Key Points

• Senseonics Holdings, Inc. has received a consensus rating of "Buy" from five brokerages, with an average target price of $1.55 over the next year.
• Significant institutional interest was noted, with Bank of America increasing its stake by 1,282.4%, now holding 915,488 shares valued at approximately $436,000.
• The stock is currently trading at $0.46, with a market cap of $373.78 million and a 1-year high of $1.40.

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) has earned an average rating of "Buy" from the five analysts that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $1.5375.

A number of research firms recently issued reports on SENS. HC Wainwright reissued a "buy" rating and set a $1.40 price target (up previously from $1.10) on shares of Senseonics in a report on Tuesday, July 8th. Lake Street Capital raised Senseonics to a "strong-buy" rating in a report on Thursday, July 17th. Barclays began coverage on Senseonics in a report on Wednesday, August 27th. They set an "overweight" rating and a $1.50 price target on the stock. TD Cowen began coverage on Senseonics in a report on Tuesday, July 15th. They set a "buy" rating and a $1.25 price target on the stock. Finally, Wall Street Zen raised Senseonics to a "sell" rating in a report on Monday, May 12th.

Institutional Investors Weigh In On Senseonics

A number of institutional investors have recently added to or reduced their stakes in the business. Beck Mack & Oliver LLC boosted its holdings in Senseonics by 16.5% in the 2nd quarter. Beck Mack & Oliver LLC now owns 176,950 shares of the company's stock valued at $84,000 after purchasing an additional 25,000 shares in the last quarter. IFP Advisors Inc boosted its holdings in Senseonics by 120.9% in the 1st quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock valued at $31,000 after purchasing an additional 26,000 shares in the last quarter. CTC Alternative Strategies Ltd. purchased a new stake in Senseonics in the 1st quarter valued at approximately $31,000. Raymond James Financial Inc. purchased a new stake in Senseonics in the 4th quarter valued at approximately $26,000. Finally, Smith Salley Wealth Management purchased a new stake in Senseonics in the 1st quarter valued at approximately $36,000. Hedge funds and other institutional investors own 12.36% of the company's stock.

Senseonics Stock Performance

Shares of SENS stock traded down $0.00 during mid-day trading on Wednesday, hitting $0.46. 3,108,361 shares of the stock were exchanged, compared to its average volume of 8,040,664. The stock's fifty day simple moving average is $0.50 and its two-hundred day simple moving average is $0.60. The stock has a market capitalization of $374.35 million, a price-to-earnings ratio of -3.53 and a beta of 0.93. Senseonics has a 12-month low of $0.25 and a 12-month high of $1.40. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.